Fig. 2From: Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE StudyAchievement of meaningful pain relief and return to normal function for first treated attack in respondents who used ubrogepant and onabotulinumtoxinABack to article page